Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Rare Virus Sickens Several Kansas City Babies

August 15, 2014 8:45 am | Videos | Comments

Doctors say a new and rare virus has sent more than a dozen babies to Kansas City hospitals.                           

TOPICS:

Vitamin D Could Affect Female Fertility

August 15, 2014 8:38 am | Videos | Comments

In vitro fertilization could be affected by the Vitamin D level of the mother. Also, the newly developed Chikungunya vaccine is doing well in trials.                 

TOPICS:

FDA Warns Consumers About Fraudulent Ebola Treatment Products

August 15, 2014 8:27 am | News | Comments

The U.S. Food and Drug Administration is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. Since the outbreak of the Ebola virus in West Africa, the FDA has seen and received consumer complaints about a variety of products claiming to either prevent the Ebola virus or treat the infection.

TOPICS:
Advertisement

FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

August 15, 2014 8:23 am | News | Comments

Genentech, a member of the Roche Group, announced that the FDA approved Avastin® (bevacizumab) in combination with paclitaxel and cisplatin or paclitaxel and topotecan for the treatment of women with persistent, recurrent or metastatic carcinoma of the cervix.

TOPICS:

FDA Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD

August 15, 2014 8:20 am | News | Comments

Boehringer Ingelheim Pharmaceuticals announced that the FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted [10 yes, 3 no] that existing data supports approval of Boehringer Ingelheim's investigational tiotropium bromide inhalation spray for long-term, once-daily maintenance treatment of bronchospasm associated with COPD.

TOPICS:

FDA Accepts Pfizer's Biologics License Application For Investigational Meningococcal B Vaccine

August 15, 2014 8:12 am | News | Comments

Pfizer announced that the FDA has accepted for review the Biologics License Application (BLA) for bivalent recombinant LP2086 (rLP2086), the company’s vaccine candidate for the prevention of invasive meningococcal disease.     

TOPICS:

Ebola Puts Focus on Drugs Made in Tobacco Plants

August 15, 2014 8:07 am | by MALCOLM RITTER, AP Science Writer | News | Comments

It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. Using plants this way — sometimes called "pharming" — can produce complex and valuable proteins for medicines. That approach, studied for about 20 years, hasn't caught on widely in the pharmaceutical industry.

TOPICS:

Scientists Racing to Test Ebola Vaccines in Humans

August 14, 2014 6:30 pm | by Matthew Perrone - Associated Press - Associated Press | News | Comments

Scientists are racing to begin the first human safety tests of two experimental Ebola vaccines, but it won't be easy to prove that the shots and other potential treatments in the pipeline really work. There are no proven drugs or vaccines for Ebola, a disease so rare that it's been hard to...

TOPICS:
Advertisement

Amgen Recalls Aranesp Prefilled Syringes in Several Countries Outside of the U.S. Due to the Presence of Visible Particulates

August 14, 2014 9:05 am | News | Comments

Amgen initiated a voluntary recall on June 26, 2014 for nine packaged lots of Aranesp (darbepoetin alfa) (500 mcg) prefilled syringes from non-U.S. distributors, wholesalers and a number of hospital pharmacies due to the potential presence of cellulose and/or polyester particles observed in a small number of syringes during a routine quality examination.

TOPICS:

Researchers Test "Bionic Pancreas" at Camp for Diabetic Kids

August 14, 2014 8:51 am | Videos | Comments

For the past few weeks, young diabetic children have attended a summer camp in Massachusetts and researchers are testing a device called the "bionic pancreas" on some of them. The device checks blood sugar every five minutes and transmits the information to a smartphone app, which figures out if the user needs insulin to lower blood sugar levels, or glucagon to raise it.

TOPICS:

Allergan Acquires LiRIS® Program from TARIS Biomedical®

August 14, 2014 8:43 am | News | Comments

Allergan has closed a transaction to acquire worldwide rights to TARIS Biomedical's® lead program, LiRIS®, which is currently in Phase 2 trials for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).      

TOPICS:

The Path to Optimized Drug Production

August 14, 2014 8:36 am | by Nancy Berg, President and CEO of the International Society for Pharmaceutical Engineering (ISPE) | Blogs | Comments

Scaling up can be a challenge; know the processes and tools for a successful transition.                                              

TOPICS:

AstraZeneca Advances Tralokinumab for Severe Asthma to Phase III

August 14, 2014 8:32 am | News | Comments

AstraZeneca announced the start of the Phase III program for tralokinumab, a potential treatment for patients with severe, inadequately controlled asthma, developed by MedImmune, the company’s global biologics research and development arm.  

TOPICS:

Study Questions Need for Most People to Cut Salt

August 14, 2014 8:23 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

A large international study questions the conventional wisdom that most people should cut back on salt, suggesting that the amount most folks consume is OK for heart health — and too little may be as bad as too much. The findings came under immediate attack by other scientists.

TOPICS:

CDC Recommends Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

August 14, 2014 8:16 am | News | Comments

Pfizer announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13 ® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein])PCV13) for routine use to help protect adults aged 65 years and older against pneumococcal disease.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading